ArticleExperimental & molecular medicine2026

Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma.

Giulia Cazzanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.